Drug Target Selection and Validation

The first book in the Computer-Aided Drug Discovery and Design series focuses on computational aspects of early drug discovery, target identification, and validation, revising classical paradigms and discussing a new network approach. It is useful for students and research scientists in drug discovery, design, kinetics, and metabolic analysis.

Format: Hardback
Length: 257 pages
Publication date: 18 May 2022
Publisher: Springer Nature Switzerland AG

The first book in the newly created book series, Computer-Aided Drug Discovery and Design, delves into the computational aspects of early drug discovery, drug target identification, and validation. It challenges and revises current classical paradigms in target and phenotypic-based drug design, incorporating still-ingrained approximations and concepts. Additionally, it explores the research in the emerging network approach concept, which encompasses kinetic selectivity and metabolic analysis. This comprehensive text covers many often-overlooked approximations and concepts in drug discovery, providing valuable insights for both students and research scientists in drug discovery, design, kinetics, and metabolic analysis. Pharmaceutical scientists, pharmaceutics, drug developers, pharmacologists, biomedical researchers in computer science, medicinal chemists, and precision medicine developers will greatly benefit from the information presented in this book. The book concludes with a chapter on chemical and structural databases, further enhancing its usefulness as a comprehensive resource for the field.

Weight: 582g
Dimension: 235 x 155 (mm)
ISBN-13: 9783030958947
Edition number: 1st ed. 2022